-
Messi meets England at last with World Cup final place on the line
-
Italy's Cannone gets four-match ban for red card against All Blacks
-
Oil extends gains after latest US strikes, tech suffers more losses
-
Co-star says Sam Neill battled pneumonia before death
-
Young Australian men falling victim to online sexual extortion: regulator
-
Armenian apricots become geopolitical battleground with Russia
-
New era for Gibraltar as border controls with Spain set to end
-
Jay-Z pays tribute to NY hometown crowd and his 30-year legacy
-
England face might of Messi's Argentina in World Cup semi-final
-
Birthday boy Yamal stands by 'no fear' comment ahead of France clash
-
Spain to go on 'front foot' against France in World Cup semi: De la Fuente
-
Trump slashes two Utah protected areas by more than 90%
-
US strikes Iran for third night as Trump says deal still 'possible'
-
Spain 'favourites' says Deschamps ahead of World Cup semi-final showdown
-
Trump vows to hit Iran 'hard,' impose Hormuz transit fees
-
Norway receive heroes' welcome in Oslo after World Cup exit
-
France and Spain prepare to duel at World Cup
-
Pickford backs England to keep cool in tense Argentina World Cup semi
-
Five Britons among foreign Spanish wildfire victims
-
Oil prices surge on US-Iran attacks; tech shares fall
-
Ukraine allies pledge more air defence, pressure Russia
-
Thomas Tuchel: England's World Cup mastermind
-
'Until the end': The tireless, traumatic search for Venezuela quake victims
-
Mbappe paradox stirs club v country debate as France face Spain
-
Trump expected to shrink protected lands in Utah: reports
-
Trump reimposes Iran naval blockade, threatens Hormuz fees
-
Twelve US states sue to block Paramount's Warner Bros. takeover
-
US vows campaign to end ICC 'threat' to Americans
-
New boss Alonso calls for Chelsea 'hunger', wants Fernandez to stay
-
Yemen govt says hit Sanaa airport, Houthis attack Saudi Arabia
-
Knight excited for future after England career ends in India defeat
-
US judge voids 'improper' Trump tax deal
-
From bombmaking to motorcycle tweaks: how Nigerian jihadists use AI
-
US appeals court revives private cases alleging Tylenol link to autism
-
Edwards vows to 'upskill' England women for Ashes after India defeat
-
Spieth adamant he has more golf majors left in him
-
Hungary MPs pass constitutional tweak to oust Orban-allied president
-
'VAR-gentina?': conspiracy theories swirl ahead of World Cup semi-finals
-
Ukraine allies meet in Paris to boost air defence, pressure Russia
-
Counter-terror police take over investigation into UK politician's killing
-
Fitzpatrick blames betting for golf fans' bad behaviour
-
McCullum sorry for England defeats after 'romantic' finish with Stokes
-
Trump declares Iran blockade back, says US will charge Hormuz fees
-
New boss Alonso calls for Chelsea 'hunger'
-
Uganda opposition leader treason trial starts without lawyers
-
Trump says US reinstates Iran blockade, will be 'paid' for guarding Hormuz
-
Iraola vows to remain true to himself at Liverpool
-
McCullum sorry for England Test defeats after Australia and India losses
-
Volkswagen confirms weighing up to 50,000 more job cuts
-
Trump says US 'taking over' Hormuz as fighting with Iran flares
Brazilian ritual root gets second life as potential anti-depressant
Long used in Indigenous Brazilian rituals, the jurema preta plant, which contains a potent psychedelic, is gaining ground as a potential treatment for depression.
At street stalls where medicinal herbs are sold, customers can buy the plant's root which contains dimethyltryptamine (DMT), a hallucinogenic substance that researchers say could be used to alleviate symptoms.
Following instructions he found on the internet, Guaracy Carvajal extracted DMT at home in 2016 from roots he bought on the street.
The 31-year-old software programmer, who had tried various treatment for chronic depression he has suffered since adolescence, said the drug makes it "feel like you've solved something in your life."
Physicist Draulio Araujo, who has conducted extensive research on the drug, said "the response is rapid. One day after treatment, (patients) already showed a significant improvement in their depression symptoms."
Yet he also warned that it "is not a magic cure" and that psychedelics "are not for everyone."
As a researcher at the Brain Institute of the Federal University of Rio Grande do Norte, Araujo and his team treated 14 people with the drug for six months.
The patients inhaled vaporized DMT, under medical supervision.
"It's common for our patients to say that something changed, that a key opened something," he said.
His patients also received psychological therapy, and some continued with conventional pharmaceutical drugs.
Neuroscientist Fernanda Palhano-Fontes, also of the Brain Institute, said "we have patients who improve significantly, others who don't improve at all."
Araujo's findings were published in the scientific journal Nature in April. In 2024, he published another study with promising results in the journal Psychedelic Medicine.
As for Carvajal, who stopped using jurema preta some time ago, he said the drug really allows a person to "start to have a lighter life."
It helped him get through a time when he was in "a state of questioning myself" about "work, day-to-day life," he said.
- Spiritual channels -
Brazil occupies a fairly prominent place in DMT research due to the substance's prominence in society, Araujo said.
While there is no ban on the cultivation or possession of jurema, which is also known as Mimosa tenuiflora, consumption of DMT is prohibited, except for religious and scientific use.
Jurema's roots are combined with other plants in a wine-like beverage that is consumed at rituals that include dancing and drums, part of Indigenous tradition in northeast Brazil where the plant grows.
"It's not hallucination," said Joyce Souza, a young woman attending a jurema ceremony in Planaltina, on the outskirts of Brasília.
"My spiritual channels become more accessible, I can communicate better with myself," Souza said.
Gathered in a house courtyard and dressed in white, the group of mostly novices waited for more seasoned practitioners to enter a trance and bring messages from ancient spirits.
Meanwhile, back in the lab, Araujo is hoping to expand his DMT research to a study of 100 patents.
"Let's say that in five years we'll have... a clear picture on when it will reach a real clinical setting," he said.
F.AbuZaid--SF-PST